Colorectal carcinogenesis involves an accumulation of genetic and epigenetic changes that lead to alterations in normal colorectal epithelium, in situ carcinoma, and finally invasive and metastatic cancers. The loss of TGF-?-induced tumor suppressor function plays a pivotal role in this transition. Resistance to TGF-? in colorectal cancers can occur through a variety of mechanisms. However, inactivating mutations in the TGF-? type II receptor and selected TGF-? signal transducers (Smad2/4), and reduced expression of receptors are not enough (around 55%) to account for the high frequency of TGF-? insensitivity among carcinomas. It is still unknown how colon cancers become resistant to the antiproliferative responses to TGF-? in the other (approximately 45%) cases. We identified a novel WD-domain containing protein STRAP (Serine Threonine Kinase Receptor Associated Protein) that binds with both TGF-? receptor complex and Smad7, and that inhibits TGF-? signaling. We have reported that STRAP and Smad7 are upregulated in colorectal cancers, stimulate cell growth, induce anchorage-independent growth and enhance tumorigenicity. Our preliminary data suggest that STRAP induces epithelial-to-mesenchymal transition (EMT) by deregulating E-cadherin independently of TGF-?. STRAP also increases the expression of claudin1 and CyclinD1 that may contribute to cell proliferation. We have evidence that STRAP upregulates active MMP9 and fibronectin, and induces cell migration and invasion. In addition, we have demonstrated that stable expression of Smad7 in colon cancer cells induces metastasis. Based on the background information, we have developed the following hypotheses: Abrogation of TGF-?-induced growth inhibition by STRAP, and TGF-?-independent effects of STRAP including induction in cell proliferation, EMT, migration and invasion are critical for the acquisition of malignant phenotype in colorectal cancer. We further hypothesize that functional cooperation between STRAP and Smad7 in blocking TGF-? tumor suppressor function is involved in colon tumor progression and metastasis. These hypotheses will be tested by following specific aims: 1) Determine the mechanism by which STRAP promotes epithelial-to-mesenchymal transition (EMT). 2) Determine the TGF-?-dependent and -independent mechanism of STRAP-regulation of cancer cell proliferation, migration and invasion. 3) Determine how functional cooperation between STRAP and Smad7 contributes to colon tumor metastasis and the mechanism of upregulation of STRAP in human colorectal cancer. The long-term objective of this study is to understand, at the molecular level, the mechanism by which colorectal tumors become resistant to TGF-? tumor suppressor effects. A better understanding of the regulators of EMT, migration, invasion and metastasis will help to improve drug development and treatment of colorectal cancer.

Public Health Relevance

The loss of transforming growth factor-? (TGF-?)-induced tumor suppressor function in tumors plays a pivotal role in the transition from normal colorectal epithelium, to in situ carcinoma, and finally invasive and metastatic colorectal cancer progression and metastasis. A better understanding of these mechanisms will help to improve drug development and treatment of this lethal disease.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Tumor Microenvironment Study Section (TME)
Program Officer
Ault, Grace S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Alabama Birmingham
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Zhang, B; Zhang, B; Chen, X et al. (2014) Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway. Br J Cancer 110:946-57
Samanta, Debangshu; Datta, Pran K (2012) Alterations in the Smad pathway in human cancers. Front Biosci (Landmark Ed) 17:1281-93
Samanta, Debangshu; Gonzalez, Adriana L; Nagathihalli, Nagaraj et al. (2012) Smoking attenuates transforming growth factor-?-mediated tumor suppression function through downregulation of Smad3 in lung cancer. Cancer Prev Res (Phila) 5:453-63
Kashikar, Nilesh D; Zhang, Wanguang; Massion, Pierre P et al. (2011) Role of STRAP in regulating GSK3? function and Notch3 stabilization. Cell Cycle 10:1639-54
Reiner, Jennifer; Ye, Fei; Kashikar, Nilesh D et al. (2011) STRAP regulates c-Jun ubiquitin-mediated proteolysis and cellular proliferation. Biochem Biophys Res Commun 407:372-7
Halder, Sunil K; Cho, Yong-Jig; Datta, Arunima et al. (2011) Elucidating the mechanism of regulation of transforming growth factor ? Type II receptor expression in human lung cancer cell lines. Neoplasia 13:912-22
Reiner, Jennifer Elisabeth; Datta, Pran K (2011) TGF-beta-dependent and -independent roles of STRAP in cancer. Front Biosci (Landmark Ed) 16:105-15
Rachakonda, G; Sekhar, K R; Jowhar, D et al. (2010) Increased cell migration and plasticity in Nrf2-deficient cancer cell lines. Oncogene 29:3703-14
Zhang, Bixiang; Halder, Sunil K; Kashikar, Nilesh D et al. (2010) Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology 138:969-80.e1-3
Kashikar, Nilesh D; Reiner, Jennifer; Datta, Arunima et al. (2010) Serine threonine receptor-associated protein (STRAP) plays a role in the maintenance of mesenchymal morphology. Cell Signal 22:138-49

Showing the most recent 10 out of 20 publications